Karen Padgett
Directeur/Membre du Conseil chez JANEL CORPORATION
Profil
Karen M.
Padgett was the founder of Novus Biologicals LLC (1996) and Breakthrough Kent Denver (2011), where she held the title of Chief Executive Officer and Co-Chairman, respectively.
Currently, she is an Independent Director at Janel Corp.
(2021 - present) and a Director at Cell IDx, Inc. (current).
Previously, she worked as a Principal at Ciba-Geigy Corp.
and Novartis Corp.
She also served as VP-Global Marketing & Antibody Business Unit at Bio-Techne Corp.
(2014 - 2019).
Ms. Padgett received her undergraduate degree from Indiana University in 1986 and her MBA from The University of Chicago Booth School of Business.
Postes actifs de Karen Padgett
| Sociétés | Poste | Début |
|---|---|---|
| JANEL CORPORATION | Directeur/Membre du Conseil | 01/10/2021 |
| Breakthrough Kent Denver | Fondateur | 01/08/2011 |
Cell IDx, Inc.
 Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Cell IDx, Inc. provides commercial physical and biological research services. The firm offers path IDx staining, imaging and analysis, and custom panel development services. The company was founded by David Schwartz and Stephen J. Kron and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Karen Padgett
| Sociétés | Poste | Fin |
|---|---|---|
| BIO-TECHNE CORPORATION | Sales & Marketing | 01/01/2019 |
Novus Biologicals LLC
 Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Directeur Général | 01/07/2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1993 |
| Ciba-Geigy Corp. | Corporate Officer/Principal | - |
Formation de Karen Padgett
| Indiana University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIO-TECHNE CORPORATION | Health Technology |
| JANEL CORPORATION | Transportation |
| Entreprise privées | 5 |
|---|---|
Novus Biologicals LLC
Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Breakthrough Kent Denver | |
| Ciba-Geigy Corp. | Health Technology |
Cell IDx, Inc.
Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Cell IDx, Inc. provides commercial physical and biological research services. The firm offers path IDx staining, imaging and analysis, and custom panel development services. The company was founded by David Schwartz and Stephen J. Kron and is headquartered in San Diego, CA. | Commercial Services |
